Tramadol for moderate cancer pain: a reappraisal

BMJ Support Palliat Care. 2024 Jan 8;13(e3):e749-e750. doi: 10.1136/spcare-2022-003819.

Authors

Tatsuma Sakaguchi¹, Toru Kajiyama², Mafumi Miyake³, Toshiro Katayama⁴

Affiliations

¹ Department of Palliative Care, Kitano Hospital, Osaka, Japan sakaguchi.tatsuma@gmail.com.
² Department of Palliative Care, Kitano Hospital, Osaka, Japan.
³ Department of Pharmacology, Kitano Hospital, Osaka, Japan.
⁴ Department of Medical Engineering, Morinomiya University of Medical Sciences, Osaka, Japan.

PMID: 35940870
DOI: 10.1136/spcare-2022-003819

No abstract available

Keywords: Cancer; Pain; Pharmacology; Supportive care.

Publication types

Letter

MeSH terms

Analgesics, Opioid / therapeutic use
Cancer Pain* / drug therapy
Humans
Neoplasms* / complications
Pain / drug therapy
Tramadol* / therapeutic use

Substances

Tramadol
Analgesics, Opioid